EWC vs XBI
iShares MSCI Canada ETF vs SPDR S&P Biotech ETF
- • XBI has the lower expense ratio at 0.35% vs 0.50% for EWC.
- • EWC pays a higher dividend yield (1.33%).
Side-by-side metrics
| Metric | EWC | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.50% | 0.35% |
Dividend yield Trailing 12-month yield. | 1.33% | 0.34% |
AUM Assets under management — bigger funds are typically more liquid. | $5.24B | $8.30B |
YTD return | 7.94% | 12.92% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.85 | 1.09 |
P/E ratio | 19.38 | — |
Last price | $57.82 | $133.66 |
Inception | — | — |
Issuer | iShares | State Street |
EWC top holdings
| RY | Royal Bank of Canada | 8.22% |
| TD | The Toronto-Dominion Bank | 5.96% |
| SHOP | Shopify Inc Registered Shs -A- Subord Vtg | 4.86% |
| ENB.TO | Enbridge Inc | 3.96% |
| BMO.TO | Bank of Montreal | 3.53% |
| CM.TO | Canadian Imperial Bank of Commerce | 3.39% |
| CNQ.TO | Canadian Natural Resources Ltd | 3.25% |
| BNS.TO | Bank of Nova Scotia | 3.15% |
| AEM.TO | Agnico Eagle Mines Ltd | 3.09% |
| BN.TO | Brookfield Corp Registered Shs -A- Limited Vtg | 3.05% |
XBI top holdings
| APLS | Apellis Pharmaceuticals Inc | 1.87% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 1.65% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 1.62% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.44% |
| TWST | Twist Bioscience Corp | 1.42% |
| SMMT | Summit Therapeutics Inc Ordinary Shares | 1.40% |
| ALKS | Alkermes PLC | 1.38% |
| TGTX | TG Therapeutics Inc | 1.37% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.36% |
| BEAM | Beam Therapeutics Inc | 1.32% |
About EWC
EWC (iShares MSCI Canada ETF) is Canadian large and mid-cap equities. Managed by iShares, the fund carries $5.2B in assets under management, an expense ratio of 0.50%, a dividend yield of 1.33%. Its largest holding is Royal Bank of Canada (RY), which represents 8.2% of the portfolio. Real Estate is the fund's largest sector exposure at 0.2%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $8.3B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.34%. Its largest holding is Apellis Pharmaceuticals Inc (APLS), which represents 1.9% of the portfolio. Financial Services is the fund's largest sector exposure at 0.2%.